Health Capital Group research
340B Entity Explorer
Estimated 340B profit and footprint for every U.S. covered entity, hospitals and federal grantees alike. Built from HRSA registrations and purchase data, Medicare cost reports and the state-mandated 340B filings from Minnesota, Rhode Island, Ohio and Vermont.
Preliminary estimates · Not for public useThe 340B figures in this tool are Health Capital Group model estimates built from public data. They are not reported numbers and will change. Health Capital Group is not responsible for errors in the public sources they draw on (HRSA, CMS cost reports, IRS Form 990 filings, NASHP and state 340B reports).
Open the Explorer
8,869
covered entities modeled
$100B
340B drug purchases in CY2025 (HRSA)
$86B
estimated 340B net profit, CY2025 (HCG model)
- One-pagers for every entity
- System and state rollups
- Star ratings from measured data
- Self-reported 340B figures, side by side